From professional translators, enterprises, web pages and freely available translation repositories.
for the comparator arms, the same lack of treatment emergent resistance was also the case for patients treated with darunavir/r in flamingo.
i komparator armene, ble det heller ikke sett behandlingsrelatert resistens hos pasienter behandlet med darunavir/r i flamingo.
in flamingo (ing114915), an open-label, randomised and active-controlled study, 484 hiv-1 infected antiretroviral naïve adults received one dose of either dolutegravir 50 mg once daily (n=242) or darunavir/ritonavir (drv/r) 800 mg/100 mg once daily (n=242), both administered with either abc/3tc or tdf/ftc.
i flamingo (ing114915), en åpenrandomisert studie med aktiv kontroll fikk 484 hiv-1-infiserte antiretroviral behandlingsnaive voksne en dose med enten dolutegravir 50 mg en gang daglig (n=242) eller darunavir/ritonavir (drv/r) 800 mg/100 mg en gang daglig (n=242), begge administrert sammen med enten abc/3tc eller tdf/ftc.
